CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net earnings	$ 8,623	$ 6,681
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	1,121	1,025
Amortization	173	177
Deferred taxes	29	0
Premium amortization, net of discount accretion	31	435
Gain on sale of loans	(140)	(272)
Reversal of provision for credit losses	(300)	(250)
Origination of loans held for sale	(5,178)	(7,798)
Proceeds from loans held for sale	5,311	8,172
Net loss (gain) on sale of premises, equipment, other real estate owned and other assets	203	(11)
Stock based compensation	112	138
Net change in accrued interest receivable and other assets	785	(8,627)
Net change in accrued interest payable and other liabilities	1,946	1,450
Net cash provided by operating activities	12,716	1,120
Securities available for sale:
Purchases	(30,928)	(439,214)
Proceeds from maturities and principal repayments	14,841	404,493
Securities held to maturity:
Proceeds from maturities and principal repayments	29,258	39,806
Net repayments of loans	23,001	42,173
Purchases of premises and equipment	(209)	(997)
Proceeds from sale of premises, equipment, other real estate owned and other assets	971	124
Net cash provided by investing activities	36,934	46,385
Cash flows from financing activities
Net change in deposits	12,173	(5,402)
Net change in securities sold under agreements to repurchase	16,627	13,886
Proceeds from FHLB advances	0	590,000
Repayment of FHLB advances	0	(655,000)
Proceeds from line of credit	2,000	0
Repayment of line of credit	(2,000)	(4,500)
Purchase of treasury stock	(5,173)	(335)
Exercise of stock options	1,316	69
Cash dividends paid	(2,744)	(2,654)
Net cash provided by (used in) financing activities	22,199	(63,936)
Net change in cash and cash equivalents	71,849	(16,431)
Cash and cash equivalents at beginning of period	145,964	89,524
Cash and cash equivalents at end of period	217,813	73,093
Supplemental disclosures of cash flow information
Interest paid	13,619	16,849
Supplemental schedule of noncash investing and financing activities
Cash dividends accrued	2,840	2,769
Transfer of loans to other real estate owned and repossessed assets	$ 0	$ 14,946